FibroGen (FGEN) Tops Q2 EPS by 14c

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($0.78), $0.14 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $29.8 million versus the consensus estimate of $36.16 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
• BMO Capital bullish on top pick Royal Caribbean as cruise tailwinds ’favorable’